REQUEST A DEMO
Total
USD $0.00
Search more companies

Cure Pharma Sp. z o.o. (Poland)

Main Activities: Department Stores
Secondary Activities: Pharmaceutical and Medicine Manufacturing | Merchant Wholesalers, Durable Goods | Retail Trade | Pipeline Transportation | Warehousing and Storage | All Other Professional, Scientific, and Technical Services | Office Administrative Services | Ambulatory Health Care Services
Full name: Cure Pharma Sp. z o.o. Profile Updated: July 04, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Polish Download a sample report

Cure Pharma Sp. z o.o. is a company based in Poland, with its head office in Lodz. The enterprise operates in the Department Stores industry. It was first established on August 16, 2018. Its’ total assets recorded a negative growth of 41.62%.

Headquarters
Ul. Zachodnia 107
Lodz; Lodzkie; Postal Code: 90-723

Contact Details: Purchase the Cure Pharma Sp. z o.o. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Cure Pharma Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Cure Pharma Sp. z o.o. report to view the information.
Incorporation Date:
August 16, 2018
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Company Performance
Financial values in the chart are available after Cure Pharma Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Operating profit (EBIT)
0%
Net Profit (Loss) for the Period
0%
Total assets
-41.62%
Total equity
-33.87%
Return on Equity (ROE)
-8.57%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?